Gemtuzumab Ozogamicin

ATC L01FX02 · 9 markets · 12 records

Gemtuzumab Ozogamicin 9 markets · 12 records Forms

AU 3 records · 2 strengths

5 mginjectionMylotarg+1MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial also in GB·ES·TW unknown

Records without a stated strength · 1 Mylotarg

EU 2 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Mylotarg、Mylotarg Refusal

US 1 records · 1 strengths

5 mg/5 mLinjectionMylotarg

GB 1 records · 1 strengths

5 mginjectionMylotarg 5mg powder for concentrate for solution for infusion vials also in AU·ES·TW

CA 1 records · 1 strengths

4.5 mgpowderMylotarg

SG 1 records · 1 strengths

5 mg/vialpowderMYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL

ES 1 records · 1 strengths

5 mginjectionMylotarg also in AU·GB·TW

TW 1 records · 1 strengths

5 mginjectionMYLOTARG 5 mg powder for concentrate for solution for infusion+1滅髓瘤凍晶注射劑5毫克 also in AU·GB·ES

HK 1 records · 1 strengths

Records without a stated strength · 1 MYLOTARG 5 mg powder for concentrate for solution for infusion

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU
5 mg injection	not recorded	Mylotarg 5mg powder for concentrate for solution for infusion vials	not recorded	Mylotarg MYLOTARG gemtuzumab ozogamicin 5 mg powder for injection vial	not recorded	Mylotarg	MYLOTARG 5 mg powder for concentrate for solution for infusion 滅髓瘤凍晶注射劑5毫克	not recorded	not recorded
5 mg/5 mL injection	Mylotarg	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
5 mg/vial powder	not recorded	not recorded	not recorded	not recorded	MYLOTARG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 5MG/VIAL	not recorded	not recorded	not recorded	not recorded
4.5 mg powder	not recorded	not recorded	Mylotarg	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Mylotarg	not recorded	not recorded	not recorded	MYLOTARG 5 mg powder for concentrate for solution for infusion	Mylotarg Mylotarg Refusal

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.